Dexamethasone versus methylprednisolone for multiple organ dysfunction in COVID-19 critically ill patients: a multicenter propensity score matching study

被引:0
作者
Ohoud Aljuhani
Ghazwa B. Korayem
Ali F. Altebainawi
Daniah AlMohammady
Amjaad Alfahed
Elaf F. Altebainawi
Mohammed Aldhaeefi
Hisham A. Badreldin
Ramesh Vishwakarma
Faisal E. Almutairi
Abeer A. Alenazi
Thamer Alsulaiman
Rahaf Ali Alqahtani
Fahad Al Dhahri
Namareq Aldardeer
Ahmed O. Alenazi
Shmeylan Al Harbi
Raed Kensara
Mai Alalawi
Khalid Al Sulaiman
机构
[1] King Abdulaziz University,Department of Pharmacy Practice, Faculty of Pharmacy
[2] Princess Nourah bint Abdulrahman University,Department of Pharmacy Practice, College of Pharmacy
[3] King Salman Specialist Hospital,Pharmaceutical Care Services
[4] Hail Health Cluster,Department of Medicine
[5] Ministry of Health,Pharmaceutical Care Department
[6] King Khalid Hospital,College of Pharmacy
[7] Hail Health Cluster,Norwich clinical trial unit, Norwich medical school
[8] King Abdulaziz Medical City,Clinical Pharmacy Department
[9] King Saud Bin Abdulaziz University for Health Sciences,Pharmaceutical Care Department
[10] King Abdullah International Medical Research Center-King Saud Bin Abdulaziz University for Health Sciences,Family Medicine Department
[11] Ministry of National Guard – Health Affairs,Pharmaceutical Care Services
[12] University of east Anglia,Pharmaceutical Care Department
[13] Pharmacy Services Administration,Pharmaceutical Care Department
[14] King Fahad Medical City,Pharmaceutical Care Services
[15] Prince Sultan Military Medical City,Clinical and Administrative Pharmacy Sciences, College of Pharmacy
[16] King Faisal Specialist Hospital & Research Center,Department of Clinical Pharmacy, College of Pharmacy
[17] King Faisal Specialist Hospital and Research Center,undefined
[18] King Abdulaziz Medical City,undefined
[19] King Abdulaziz Medical City,undefined
[20] King Abdulaziz Medical City,undefined
[21] Howard University,undefined
[22] University of Hail,undefined
[23] King Abdulaziz Medical City (KAMC) - Ministry of National Guard Health Affairs (MNGHA),undefined
[24] King Abdullah International Medical Research Center/King Saud bin Abdulaziz University for Health Sciences,undefined
来源
BMC Infectious Diseases | / 24卷
关键词
COVID-19; SARS-Cov-2; Dexamethasone; Methylprednisolone; Critically ill; ICUs; 30-day mortality; In-hospital mortality; Ventilation free days (VFDs);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 185 条
[1]  
Pinzón MA(2021)Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia PLoS One 16 e0252057-198
[2]  
Ortiz S(2021)Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort Chest 160 187-1355
[3]  
Holguín H(2020)Rate of intensive care unit admission and outcomes among patients with coronavirus: a systematic review and meta-analysis PLoS One 15 e0235653-187
[4]  
Betancur JF(2021)Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: a multicentre retrospective cohort study Lancet Reg Heal Eur 11 100243-506
[5]  
Cardona Arango D(2020)Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy JAMA Intern Med 180 1345-978
[6]  
Laniado H(2021)Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): a multicenter cohort study Int J Infect Dis IJID Off Publ Int Soc Infect Dis 105 180-815
[7]  
González J(2020)Virology, pathogenesis, diagnosis and in-line treatment of COVID-19 Eur J Pharmacol 883 173375-1502
[8]  
Benítez ID(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet (London, England) 395 497-807
[9]  
Carmona P(2020)Role of corticosteroid in the management of COVID-19: a systemic review and a clinician’s perspective Diabetes Metab Syndr 14 971-704
[10]  
Santisteve S(2021)Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider Ann Rheum Dis 80 803-1148